170 related articles for article (PubMed ID: 23308126)
21. Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling.
Bie N; Zhao X; Li Z; Qi G
J Immunother; 2016 Sep; 39(7):260-8. PubMed ID: 27428264
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Tan CJ; Qiu SJ; Yu Y; Huang XW; Tang ZY
J Cancer Res Clin Oncol; 2009 May; 135(5):715-22. PubMed ID: 19002496
[TBL] [Abstract][Full Text] [Related]
23. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
[TBL] [Abstract][Full Text] [Related]
25. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Shen B; Chu ES; Zhao G; Man K; Wu CW; Cheng JT; Li G; Nie Y; Lo CM; Teoh N; Farrell GC; Sung JJ; Yu J
Br J Cancer; 2012 Apr; 106(9):1486-94. PubMed ID: 22472882
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin.
Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2018 Aug; 10(11):951-969. PubMed ID: 30114953
[TBL] [Abstract][Full Text] [Related]
27. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
28. Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.
Foy KC; Wygle RM; Miller MJ; Overholser JP; Bekaii-Saab T; Kaumaya PT
J Immunol; 2013 Jul; 191(1):217-27. PubMed ID: 23698748
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.
Chen XP; Luo JS; Tian Y; Nie CL; Cui W; Zhang WD
Biomed Res Int; 2015; 2015():241983. PubMed ID: 26839882
[TBL] [Abstract][Full Text] [Related]
30. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
[TBL] [Abstract][Full Text] [Related]
31. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
32. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
[TBL] [Abstract][Full Text] [Related]
33. GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Li SQ; Lin J; Qi CY; Fu SJ; Xiao WK; Peng BG; Liang LJ
Hepatogastroenterology; 2014; 61(130):278-84. PubMed ID: 24901124
[TBL] [Abstract][Full Text] [Related]
34. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
36. Nanosecond pulsed electric field (nsPEF) treatment for hepatocellular carcinoma: a novel locoregional ablation decreasing lung metastasis.
Yin S; Chen X; Hu C; Zhang X; Hu Z; Yu J; Feng X; Jiang K; Ye S; Shen K; Xie H; Zhou L; James Swanson R; Zheng S
Cancer Lett; 2014 May; 346(2):285-91. PubMed ID: 24462824
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
38. Heparanase-1 is upregulated by hepatitis C virus and favors its replication.
Gallard C; Lebsir N; Khursheed H; Reungoat E; Plissonnier ML; Bré J; Michelet M; Chouik Y; Zoulim F; Pécheur EI; Bartosch B; Grigorov B
J Hepatol; 2022 Jul; 77(1):29-41. PubMed ID: 35085593
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H(22) hepatocellular carcinoma.
Zhao X; Xi S; Wang Y; Xu Y; Pollock G; Su Y; Cheng Y; Loy G; Liu P
J Tradit Chin Med; 2017 Feb; 37(1):88-95. PubMed ID: 29957915
[TBL] [Abstract][Full Text] [Related]
40. [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells].
Han XM; Wang HJ; Yang JM; Zhou YL; Tao HQ; Gao H; Ye ZY
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):10-4. PubMed ID: 19538861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
